-
Fall Seminar
Join us in person or virtually for a seminar featuring some of our ongoing pharmacoepidemiology work.
For more information, click here -
Suda Publishes Multiple Papers on Dental Prescribing
CP3 Associate Director Dr. Katie Suda, an expert on dental prescribing, recently published multiple papers:
Read more about Dr. Suda's work here
Serious opioid-related adverse outcomes associated with opioids prescribed by dentists
Barriers to and facilitators of opioid prescribing by dentists in the United States
Impact of Hydrocodone Rescheduling on Dental Prescribing of Opioids
High Prescribing of Antibiotics is Associated with High Prescribing of Opioids in Medical and Dental Providers -
CP3 Hosted First Pharmacoequity Conference
On May 20, CP3 hosted its Inaugural Pharmacoequity Conference, with Keynote Speaker Dr. Jasmine Marcelin and research and policy panels.
CP3 Events Page -
Pitt Awarded $3.5M to Improve Disparities in Insulin Access
The University of PIttsburgh has been awarded an unprecedented $3.5M from The Leona M. and Harry B. Helmsley Charitable Trust to study effectiveness of long-acting analogue insulin in children and young people with Type 1 diabetes. CP3 Faculty Affiliate Dr. Jing Luo will be the study PI. This work addresses disparities in insulin access for kids in resource-poor areas and will lead to improved insulin access globally.
Read more about the grant
Improving the Quality, Safety and Efficiency of Medication Use
While prescription drugs are used by 80% of Americans, the improper, unsafe use of medications leads to billions of dollars of avoidable healthcare costs. The goal of the CP3 research program is to improve patient and prescriber decision-making, and inform the regulation and coverage of pharmaceuticals.
